Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.590
0.00 (0.00%)
At close: Apr 6, 2026, 4:00 PM EDT
1.590
0.00 (0.00%)
Pre-market: Apr 7, 2026, 8:36 AM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $22.81 million as of April 7, 2026. Its market cap has decreased by -35.49% in one year.
Market Cap
22.81M
Enterprise Value
23.24M
1-Year Change
-35.49%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $22.81M, a decrease of -74.27%. That is a compound annual growth rate of -24.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 22.81M | 61.28% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 24.51M |
| Plus Therapeutics | 24.43M |
| Boundless Bio | 24.20M |
| Neuphoria Therapeutics | 23.77M |
| Quantum BioPharma | 23.46M |
| Skye Bioscience | 23.30M |
| Vistagen Therapeutics | 23.24M |
| Outlook Therapeutics | 22.91M |